Dermatology Patient Recall Software for Skin Checks and Biopsy Follow-Up (2026)

Dermatology patient recall software watches the intervals your physicians already set, the annual skin check after a melanoma or basal cell diagnosis, the recheck after a biopsy or excision, the monthly visit and lab rhythm on isotretinoin, the quarterly check on a biologic for psoriasis, and reaches each patient when the window opens and no visit is on the schedule. It reads the chart, the orders, and the visit history from ModMed, Nextech, athenahealth, or eClinicalWorks, contacts the patient by phone, text, and email in one thread, books the visit, and reports found, reached, booked, and seen. The right tool replaces the tickler file and the manual chart pull with a scan that never stops. Dermatology carries more protocol-driven recall intervals than most office-based specialties, and every one of them is a place a patient can quietly fall off the schedule. Recall is how a practice closes those loops at scale.

This guide covers the recall intervals that matter in dermatology, how often they are actually kept, how recall software should work against your EHR, and a six-step program for running it well.

Key Takeaways

• Melanoma follow-up guidance calls for an individualized schedule, at least annually and as often as every 3 to 12 months depending on recurrence risk, with Stage IIIB to C and resected Stage IV melanoma following a fixed schedule for up to ten years.
• A 2026 retrospective cohort found adherence to annual dermatology surveillance after a melanoma diagnosis fell from 44% at two years to 19% at five years and 7% at ten years.
• Patients with a first basal cell carcinoma have a 29.2% chance of a second one within five years, which is why a missed annual check is a clinical gap, not only a scheduling one.
• Isotretinoin requires a visit and lab review roughly every 30 days under the federal iPLEDGE program, and a missed window can lapse the prescription.
• Recall software earns its place by reading the chart continuously and reporting found, reached, booked, and seen, by pathway.

The Data Behind the Decision

The obligations are written into guidelines. The AAD Guidelines of Care for the Management of Primary Cutaneous Melanoma call for individualized follow-up based on recurrence risk, and a 2024 review in Cancers, 2024 lays out the detail: clinicians should evaluate patients at least annually and as often as every 3 to 12 months depending on tumor thickness, ulceration, and mitotic rate, and Stage IIIB to C or resected Stage IV melanoma should be evaluated every three months for three years, every six months for the next two years, and annually for five years after that. None of these windows books itself.

The gap between the guideline and the schedule is measurable and it widens over time. A retrospective cohort study published in Archives of Dermatological Research, 2026 found adherence to annual dermatology surveillance after a melanoma diagnosis was 44% at two years, 19% at five years, and 7% at ten years. The same body of research links better follow-up adherence to lower melanoma-specific mortality, so the decline is not a paperwork problem.

Skin cancer history compounds the stakes. In a Dutch cohort of 2,483 patients with a first basal cell carcinoma, 29.2% developed at least one more within five years (Flohil et al., British Journal of Dermatology, 2011). A patient who skipped last year's check is not simply overdue; they are carrying a real, rising probability of disease that nobody is watching for.

Outside oncology, the recall intervals are shorter and more procedural. Isotretinoin is federally regulated under iPLEDGE, which requires a visit and pregnancy test roughly every 30 days for patients who can become pregnant, and a missed window can make the account inactive and force a new waiting period before the prescription can resume. Biologic therapy for psoriasis has its own drop-off: in a study of Medicare patients starting a biologic, only 38% remained adherent during the first 12 months and 46% discontinued (Doshi et al., Journal of the American Academy of Dermatology, 2016). Since 82% of patients try to book care outside a practice's regular office hours, a recall program that only calls during business hours reaches a fraction of the list.

What does dermatology patient recall software actually do?

It starts with rules, written by your physicians. Each rule names a trigger in the chart and a window: a melanoma or high-risk-mole diagnosis opens an annual or staged surveillance interval; a biopsy or excision opens a recheck window; an isotretinoin prescription opens a roughly 30-day visit-and-lab cadence; a new biologic opens a quarterly monitoring visit; a mole-mapping program opens its own annual interval.

Then the software scans the EHR against those rules, continuously. It reads diagnoses, orders, results, and the appointment book from ModMed, Nextech, athenahealth, or eClinicalWorks and flags every patient whose interval has opened with no visit on the schedule. It contacts each one in the practice's voice, in a two-way thread that names the reason and offers real appointment times. When the patient replies, the thread books the visit. When the patient says the lab was already drawn elsewhere, the thread routes that to staff. Every step is logged as found, reached, booked, and seen.

Recall is a different job from reactivation. Recall reaches a patient who is due; reactivation reaches a patient with no visit in twelve months, who counts as a new patient when they return. We cover the distinction, with dermatology examples, in our guide to AI patient reactivation software and in reminders vs. recall vs. reactivation.

How is recall different in dermatology than in primary care?

Primary care recall is mostly a single annual visit. Dermatology recall is dense and clinical, and the intervals often overlap on the same patient. A melanoma survivor may carry a staged surveillance schedule and a separate mole-mapping interval that do not line up. An isotretinoin patient has a monthly visit tied to a lab result that must post before the next fill. A biologic patient has a quarterly check that, if skipped, shows up later as a flare rather than a missed appointment.

Two consequences follow. The rules have to live in the practice's clinical language, not a generic wellness template built for annual physicals. And the outreach has to be specific: a patient told her six-month surveillance visit with Dr. Patel is due, with three real times offered, responds. The same patient ignores a generic reminder to schedule her annual visit. Recall in dermatology needs a two-way conversation and one shared memory of the patient, not a mail merge.

What should recall software connect to, and what does it cost the staff?

It should connect to the EHR and the schedule, so it sees results as they post and never contacts a patient who already has the visit booked. An outside-lab result or a prior pathology report should close the interval without a phone call. Booked patients should reach your front desk with every detail attached. See our integrations page for the systems Clinekt connects to.

The staff cost should be close to zero. A recall program that depends on a medical assistant working a spreadsheet every Friday runs for two months and stops. The right design gives staff only the exceptions: the decline, the insurance change, the symptom report. For the general category, see patient recall software.

How to Run Patient Recall in a Dermatology Practice: 6 Steps

1. Write the intervals down. Document every protocol interval with your physicians: melanoma surveillance by stage, biopsy and excision rechecks, isotretinoin's roughly 30-day visit and lab cadence, quarterly biologic monitoring, and mole-mapping intervals.
2. Map each interval to the chart. Identify the diagnosis code, order, result, or procedure code in your EHR that opens the window. This is the step most practices skip, and it is why their recall lists are wrong.
3. Run the first scan and review it clinically. The first list will include patients who moved, switched providers, or completed care elsewhere. Have a nurse review a sample before outreach starts.
4. Launch outreach in the practice's voice. Text and email first, phone for patients who do not reply or prefer calls. Each message names the physician and the reason and offers real times.
5. Route exceptions to staff with context. Symptom reports, outside results, and declines go to a person, with the thread attached, not to a shared inbox.
6. Review found, reached, booked, seen by pathway monthly. If surveillance patients book but isotretinoin patients do not, change the message, not the program.

What Should Still Go to a Human?

The interval is the software's job. The decision is the physician's. Whether a mole needs a biopsy or continued watching, whether an isotretinoin dose needs adjustment, and whether a biologic patient reporting a flare should be seen sooner belong with the dermatologist. Billing disputes, prior authorization questions, and any patient who reports a new or changing lesion, fever, or a concerning reaction in the thread should reach a nurse immediately, with the full conversation attached. Recall software should make those handoffs faster, not replace them.

Where Clinekt Fits

Clinekt is patient engagement software: patient engagement that ends in a booked visit. Our AI agents share one memory of every patient. The Inbound Agent answers every call, text, and new patient on the website the moment they arrive, in the practice's name, around the clock. The Recall Agent is the one that does this job: it continuously scans your records for overdue surveillance, biopsy and excision rechecks, isotretinoin and biologic monitoring windows, and mole-mapping intervals, reaches those patients by phone, text, and email in one two-way thread, books them back, and reports found, reached, booked, and seen. The Outbound Agent reaches net-new demand, and the Care Agent runs monthly check-ins between visits. We work alongside ModMed, Nextech, athenahealth, eClinicalWorks, and the other major systems, and go-live is same day for the website agent.

The proof we can share is from a different specialty. Baldwin Bone and Joint, an orthopedic group, produced 263 qualified surgical leads and 159 booked appointments, a 60% booking rate, in a single quarter (read the case study). That is an orthopedic result, not a dermatology one, and we say so plainly. The mechanism, a scan of the record plus a two-way conversation that ends in a booked visit, is the same one that closes a surveillance interval. More than one million patient interactions have been completed across the platform. See how it applies to skin checks, biopsy rechecks, and isotretinoin and biologic monitoring on our dermatology page and the Recall Agent page.

Estimate what your open surveillance and monitoring intervals are worth with the leakage calculator, or book a demo to see the first scan run against your protocols.

Frequently Asked Questions

What is the difference between recall and appointment reminders in dermatology?
Reminders go to patients who already have an appointment. Recall goes to patients whose next visit is due by protocol but was never booked: the annual skin check after a melanoma diagnosis, the biopsy recheck, the isotretinoin lab visit, the biologic monitoring check. Most dermatology practices have reminders and no recall.

Which recall intervals matter most in a dermatology practice?
Melanoma and high-risk-mole surveillance by stage, biopsy and excision rechecks, the roughly 30-day isotretinoin visit and lab cadence, quarterly biologic monitoring for psoriasis, and mole-mapping intervals. Your physicians set the intervals; the software enforces them.

Does recall software need to connect to our EHR?
Yes. Recall that runs off a manually exported list is out of date the day it is exported. Clinekt connects to ModMed, Nextech, athenahealth, and eClinicalWorks, so the scan runs against live orders, results, and the schedule, and booked patients reach your front desk with the conversation attached.

How does recall software handle isotretinoin and biologic monitoring windows?
The rule is written from the prescription date and the required visit-and-lab cadence, roughly every 30 days for isotretinoin and quarterly for most biologics. The software flags the patient when the window opens, reaches them before the lapse, and routes any reported side effect or flare to a nurse.

Can recall software report results in a way the practice administrator can trust?
The metric set is found, reached, booked, and seen, by pathway. That lets an administrator see, for example, that 90 surveillance patients were overdue, 74 were reached, 58 booked, and 52 were seen, rather than a count of messages sent.

Every open interval in your chart is a patient waiting to be asked. Put your numbers into the leakage calculator, then schedule a demo and we will show you the list your EHR already contains.

Keep reading: our guide to patient reactivation software for dermatology practices, which explains how recall and reactivation differ, dermatology patient engagement software, and what is patient recall.